The Pharmacist's Guide to Drug Eruptions and Interactions

When a drug is administered and an adverse reaction occurs, the usual first port of call is the pharmacist. This guide allows the pharmacist to check the symptoms against the drug or identify the drug using the visible dermatological symptoms.

---

This is a concise guide for pharmacists and other health care professionals on the adverse cutaneous side effects of 700 commonly prescribed and over-the-counter drugs, cross-indexed by generic and more than 4,200 trade names. It classifies adverse reactions in four categories: skin, hair, nail, and other, including mucous membranes, teeth, muscle, and other forms of reactions. Based upon the newly published 2000 edition of Dr. Litt's immensely popular, widely used and acclaimed ("as important as the annual PDR books") Drug Eruption Reference Manual, this pocket guide version includes all the data, less references and illustrations, of the larger manual, identifying, for each generic drug, trade names and manufacturers, drug type or class or group, clinically important or potentially serious drug interactions, and pertinent notes. It also contains a list of other, less common trade-name drugs from the U.S.A. and elsewhere. Some of the seventy newer generic drugs in the past year included in this edition are (trade names in parentheses): amprenavir (Agenerase), bretylium (Bretylol), candesartan (Atacand), celecoxib (Celebrex), dorzolamide (Trusopt), efavirenz (Sustiva), fludarabine (Fludara), ivermectin (Stromectol), leflunomide (Arava), mirtazapine (Remeron), miglitol (Glyset), olopatadine (Patanol), pentosan (Elmiron), quinupristin/dalfopristin (Synercid), Rizatriptan (Maxalt), Rofecoxib (Vioxx), Tamsulosin (Flomax), Telmisartan (Micardis), zaleplon (Sonata), and others. A vital resource for physicians and residents and the only work of its kind, Litt's Pocket Guide to Drug Eruptions and Interactions is conveniently formatted in carry-along size for quick reference in the doctor's office and on hospital rounds and consultations. Includes index of trade and generic drug names.